☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Out-Licenses
Boston Signs Out-License and Option Agreement with GSK to Advance Two Programs for Oncology and CNS Disorders
March 19, 2021
GSK Out Licenses its Tuberculosis Vaccine (M72/AS01E ) to Bill & Melinda Gates Medical Research Institute
January 28, 2020
Amgen Out-Licenses its AMG 714 (PRO-015) Candidate to Provention to Treat Celiac Disease
November 5, 2018
Mustang Bio Licenses Gene Therapy from St. Jude Children Hospital to treat X-SCID (bubble boy) in newborns
August 14, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.